Evidence map›Paper›PMID 34522297›Full record

ArticleChemical science2021

Conformational interplay in hybrid peptide-helical aromatic foldamer macrocycles.

Sebastian Dengler, Pradeep K Mandal, Lars Allmendinger, Céline Douat, Ivan Huc

Abstract read
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Design and Engineering of Miniproteins.ACS bio & med chem Au · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sebastian DenglerDepartment of Pharmacy and Center for Integrated Protein Science, Ludwig-Maximilians-Universität Butenandtstraße 5-13 D-81377 Munich Germany ivan.huc@cup.lmu.de.ORCID https://orcid.org/0000-0002-0770-0267
Pradeep K MandalDepartment of Pharmacy and Center for Integrated Protein Science, Ludwig-Maximilians-Universität Butenandtstraße 5-13 D-81377 Munich Germany ivan.huc@cup.lmu.de.ORCID https://orcid.org/0000-0001-5996-956X
Lars AllmendingerDepartment of Pharmacy and Center for Integrated Protein Science, Ludwig-Maximilians-Universität Butenandtstraße 5-13 D-81377 Munich Germany ivan.huc@cup.lmu.de.
Céline DouatDepartment of Pharmacy and Center for Integrated Protein Science, Ludwig-Maximilians-Universität Butenandtstraße 5-13 D-81377 Munich Germany ivan.huc@cup.lmu.de.ORCID https://orcid.org/0000-0003-2678-1047
Ivan HucDepartment of Pharmacy and Center for Integrated Protein Science, Ludwig-Maximilians-Universität Butenandtstraße 5-13 D-81377 Munich Germany ivan.huc@cup.lmu.de.ORCID https://orcid.org/0000-0001-7036-9696

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrocyclic peptides are an important class of bioactive substances. When inserting an aromatic foldamer segment in a macrocyclic peptide, the strong folding propensity of the former may influence the conformation and alter the properties of the latter. Such an insertion is relevant because some foldamer-peptide hybrids have recently been shown to be tolerated by the ribosome, prior to forming macrocycles, and can thus be produced using an

Identifiers

PMID34522297
PMCPMC8386670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.